Synonyms: AFN-1720 | Debio 1450 | Debio1450
Compound class:
Synthetic organic
Comment: Afabicin (DEBIO 1450) is an inhibitor of bacterial Fabl, the NADH-dependent enoyl reductase from the type II bacterial fatty acid biosynthesis pathway (FAS-II) [3]. This is a prodrug whose active metabolite is DEBIO 1452 (previously AFN-1252; PubChem CID: 10407120) [1].
|
|
Classification | |
Compound class | Synthetic organic |
Is prodrug? | Yes |
Active form | DEBIO 1452 |
IUPAC Name |
[6-[(E)-3-[methyl-[(3-methyl-1-benzofuran-2-yl)methyl]amino]-3-oxoprop-1-enyl]-2-oxo-3,4-dihydro-1,8-naphthyridin-1-yl]methyl dihydrogen phosphate |
International Nonproprietary Names | |
INN number | INN |
10413 | afabicin |
Synonyms |
AFN-1720 | Debio 1450 | Debio1450 |
Database Links | |
Specialist databases | |
Antibiotic DB | Afabicin dephosphono |
Other databases | |
CAS Registry No. | 1518800-35-5 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL4297501 |
GtoPdb PubChem SID | 405560195 |
PubChem CID | 72696796 |
Search Google for chemical match using the InChIKey | HFYMDQMXVPJNTH-VQHVLOKHSA-N |
Search Google for chemicals with the same backbone | HFYMDQMXVPJNTH |
Search PubMed clinical trials | afabicin |
Search PubMed titles | afabicin |
Search PubMed titles/abstracts | afabicin |
UniChem Compound Search for chemical match using the InChIKey | HFYMDQMXVPJNTH-VQHVLOKHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | HFYMDQMXVPJNTH-VQHVLOKHSA-N |